SS
Schonfeld Strategic Advisors LLC disclosed a 6.5% stake in INBX
Schonfeld Strategic Advisors LLC reported owning 6.5% of Inhibrx Biosciences, Inc. (INBX) (952,959 shares) in a Schedule 13G filed Nov 13, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 13, 2026
- Source
- Schedule 13G